Joseph A Kaufman
Examiner (ID: 10129)
Most Active Art Unit | 3754 |
Art Unit(s) | 3752, 3993, 3727, 3754, 3108, 3104 |
Total Applications | 1964 |
Issued Applications | 1543 |
Pending Applications | 181 |
Abandoned Applications | 196 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7545261
[patent_doc_number] => 08053232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing'
[patent_app_type] => utility
[patent_app_number] => 11/040634
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13335
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053232.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040634 | Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing | Jan 20, 2005 | Issued |
Array
(
[id] => 5672578
[patent_doc_number] => 20060177933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing'
[patent_app_type] => utility
[patent_app_number] => 11/041155
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 15621
[patent_no_of_claims] => 156
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041155 | Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing | Jan 20, 2005 | Abandoned |
Array
(
[id] => 5219799
[patent_doc_number] => 20070161110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter'
[patent_app_type] => utility
[patent_app_number] => 10/586142
[patent_app_country] => US
[patent_app_date] => 2005-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 24998
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586142
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586142 | Methods for producing minus-strand RNA viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken β-actin promoter | Jan 19, 2005 | Issued |
Array
(
[id] => 6977404
[patent_doc_number] => 20050287120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Cancer - targeted viral vectors'
[patent_app_type] => utility
[patent_app_number] => 11/032757
[patent_app_country] => US
[patent_app_date] => 2005-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7710
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287120.pdf
[firstpage_image] =>[orig_patent_app_number] => 11032757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/032757 | Cancer - targeted viral vectors | Jan 10, 2005 | Abandoned |
Array
(
[id] => 4772586
[patent_doc_number] => 20080058245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Vectors for Recombinant Protein Expression in E. Coli'
[patent_app_type] => utility
[patent_app_number] => 10/585440
[patent_app_country] => US
[patent_app_date] => 2005-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 18092
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058245.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585440
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585440 | Vectors for Recombinant Protein Expression in E. Coli | Jan 5, 2005 | Abandoned |
Array
(
[id] => 7039339
[patent_doc_number] => 20050158773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Direct identification and mapping of RNA transcripts'
[patent_app_type] => utility
[patent_app_number] => 11/022102
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7536
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158773.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022102
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022102 | Direct identification and mapping of RNA transcripts | Dec 22, 2004 | Abandoned |
Array
(
[id] => 7045601
[patent_doc_number] => 20050250196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Recombinant microorganisms expressing an oligosaccharide receptor mimic'
[patent_app_type] => utility
[patent_app_number] => 11/018745
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25282
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11018745
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/018745 | Recombinant microorganisms expressing an oligosaccharide receptor mimic | Dec 19, 2004 | Abandoned |
Array
(
[id] => 8016917
[patent_doc_number] => 08137960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Bovine adeno-associated viral (BAAV) vector and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/581228
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 21
[patent_no_of_words] => 35326
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/137/08137960.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581228
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581228 | Bovine adeno-associated viral (BAAV) vector and uses thereof | Dec 5, 2004 | Issued |
Array
(
[id] => 8317085
[patent_doc_number] => 08231861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-31
[patent_title] => 'Pancreatitis'
[patent_app_type] => utility
[patent_app_number] => 10/579865
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 18
[patent_no_of_words] => 7538
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10579865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579865 | Pancreatitis | Nov 18, 2004 | Issued |
Array
(
[id] => 533577
[patent_doc_number] => 07176029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-13
[patent_title] => 'Cloning and/or sequencing vector'
[patent_app_type] => utility
[patent_app_number] => 10/994208
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4506
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/176/07176029.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994208
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994208 | Cloning and/or sequencing vector | Nov 18, 2004 | Issued |
Array
(
[id] => 6912307
[patent_doc_number] => 20050176065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Target sequences for synthetic molecules'
[patent_app_type] => utility
[patent_app_number] => 10/970635
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14324
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176065.pdf
[firstpage_image] =>[orig_patent_app_number] => 10970635
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/970635 | Target sequences for synthetic molecules | Oct 21, 2004 | Abandoned |
Array
(
[id] => 6905495
[patent_doc_number] => 20050100890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Methods for producing and using in vivo pseudotyped retroviruses'
[patent_app_type] => utility
[patent_app_number] => 10/964574
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15629
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100890.pdf
[firstpage_image] =>[orig_patent_app_number] => 10964574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/964574 | Methods for producing and using in vivo pseudotyped retroviruses | Oct 12, 2004 | Abandoned |
Array
(
[id] => 6905547
[patent_doc_number] => 20050100942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Nucleic acid sequences and methods for identifying compounds that affect RNA/RNA binding protein interactions and mRNA functionality'
[patent_app_type] => utility
[patent_app_number] => 10/963062
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6701
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20050100942.pdf
[firstpage_image] =>[orig_patent_app_number] => 10963062
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/963062 | Nucleic acid sequences and methods for identifying compounds that affect RNA/RNA binding protein interactions and mRNA functionality | Oct 11, 2004 | Abandoned |
Array
(
[id] => 7965237
[patent_doc_number] => 07939266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-10
[patent_title] => 'Treatment of transformed or infected biological cells'
[patent_app_type] => utility
[patent_app_number] => 10/961320
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9606
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/939/07939266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10961320
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/961320 | Treatment of transformed or infected biological cells | Oct 7, 2004 | Issued |
Array
(
[id] => 5199705
[patent_doc_number] => 20070299023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'P185Neu-Encoding Dna and Therapeutical Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 10/574897
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 5959
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574897
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574897 | P185 Neu-encoding DNA and therapeutical uses thereof | Oct 5, 2004 | Issued |
Array
(
[id] => 5071778
[patent_doc_number] => 20070192880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Horming response element binding transregulators'
[patent_app_type] => utility
[patent_app_number] => 10/574322
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 55915
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20070192880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574322
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574322 | Horming response element binding transregulators | Oct 3, 2004 | Abandoned |
Array
(
[id] => 7161027
[patent_doc_number] => 20050084844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Genetic screen for bioactive peptides'
[patent_app_type] => utility
[patent_app_number] => 10/953658
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11839
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10953658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/953658 | Genetic screen for bioactive peptides | Sep 28, 2004 | Issued |
10/491707 | Methods for identifying agents that prevent palindrome formation and gene amplification in mammalian cells | Sep 26, 2004 | Abandoned |
Array
(
[id] => 5828213
[patent_doc_number] => 20060063259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination'
[patent_app_type] => utility
[patent_app_number] => 10/946484
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 21855
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10946484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/946484 | Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination | Sep 20, 2004 | Issued |
Array
(
[id] => 6917670
[patent_doc_number] => 20050095231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Modified adenovirus containing a fiber replacement protein'
[patent_app_type] => utility
[patent_app_number] => 10/944496
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21022
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095231.pdf
[firstpage_image] =>[orig_patent_app_number] => 10944496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/944496 | Modified adenovirus containing a fiber replacement protein | Sep 16, 2004 | Abandoned |